Follow Us:
Login
Register
Logout
My Profile
My Courses
Courses
Series
Specialties
Hematology/Oncology
Primary Care
Neurology
Cardiology
Psychiatric Medicine
Asthma & Allergies
Emergency Medicine
Endocrinology
Pediatrics
Infectious Disease
Pharmacy
Events
COVID-19
Home
» Expert Illustrations & Commentaries Live: The Future of JAK/TYK2 Inhibition in the Treatment of Psoriasis
Expert Illustrations & Commentaries Live: The Future of JAK/TYK2 Inhibition in the Treatment of Psoriasis
CME: 1.0
February 18, 2022
No Comments
Email
/
Print
/
Reprints
/
|
More
/
Text Size+
Larger
Smaller
[X]
Related Articles
E2: Evidence and Expert Insights in Advances in the Treatment of Atopic Dermatitis
Targeting New Pathways in Alopecia Areata: The Role of JAK Inhibitors
2022 Updates: Understanding the Changing Treatment Landscape of Chronic Rhinosinusitis – Patient Simulations
Source:
https://learning.freecme.com/a/39076P3nD8bF
Post a comment to this article
Name
*
E-mail
(will not be displayed)
*
Subject
Comment
*
Report Abusive Comment
Thank you for helping us to improve our forums. Is this comment offensive? Please tell us why.
More